COMBIGENE AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.3 SEK | +2.80% |
|
+0.95% | +18.22% |
| 05-27 | CombiGene Appoints New Chief Scientific Officer | MT |
| 05-27 | Combigene AB Appoints Annika Ericsson as New Chief Scientific Officer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMBIGENE AB | Bio Therapeutic Drugs | +2.80% | +0.95% | +18.22% | -56.44% | -87.48% | 6M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- COMBI Stock
- Charts CombiGene AB
- Comparison Chart
